LINC01193

Across TCGA pan-cancer cohorts, LINC01193 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC01193 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC01193 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01193 expression acts as an unfavorable survival marker, although some lineages such as LGG and SKCM show a favorable association.

UVM, KICH, and STAD are the cancer types where LINC01193 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	II,III,IV	0.270	0.657	<.001	108	view →
KICH	DFS	Tertile	All	0.661	0.949	<.001	73	view →
STAD	OS	Tertile	III,IV	0.495	0.664	.006	63	view →
LGG	DFS	Median	All	0.833	0.647	<.001	50	view →
HNSC	DFS	Tertile	III,IV	0.180	0.328	.003	48	view →
THCA	DFS	Tertile	All	0.377	0.852	<.001	45	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	39	view →
UCS	OS	Tertile	IV	0.224	0.694	.004	36	view →
BLCA	OS	Tertile	All	0.502	0.714	.012	30	view →
PCPG	OS	Tertile	All	0.888	1.000	.002	24	view →
BRCA	OS	Tertile	IV	0.247	0.785	.016	18	view →
COAD	DFS	Tertile	All	0.213	0.516	.009	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC01193–UVM (OS)

Open the UVM breakdown →